Recent News

• 05.29.2025 - IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
• 05.05.2025 - IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
• 04.28.2025 - CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
• 04.28.2025 - IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
• 03.10.2025 - IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
• 02.13.2025 - IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
• 01.30.2025 - IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

Recent Filings

• 05.05.2025 - EX-99.1 EX-99.1
• 05.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.05.2025 - 8-K Current report
• 04.30.2025 - ARS Annual Report to Security Holders
• 04.30.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.07.2025 - 4/A Statement of changes in beneficial ownership of securities
• 04.04.2025 - 4/A Statement of changes in beneficial ownership of securities
• 04.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]